Please try another search
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Scott Leftwich | 61 | 2019 | Independent Vice-Chairman of the Board |
Santosh Kesari | - | - | Member of Medical Advisory Board |
Karen Aboody | - | - | Member of Medical Advisory Board |
George K. Ng | 49 | 2019 | Director |
Dmitriy Zamarin | - | 2021 | Member of Scientific Advisory Board |
Maciej S. Lesniak | - | - | Member of Medical Advisory Board |
Ashok Srivastava | - | - | Member of Scientific Advisory Board |
Ewa K. Carrier | - | - | Member of Medical Advisory Board |
Alan R. Stewart | 59 | 2023 | Independent Director |
W.K. Alfred Yung | - | 2022 | Member of Medical Advisory Board |
James A. Schoeneck | 65 | 2020 | Independent Director |
David T. Curiel | - | 2024 | Member of Scientific & Medical Advisory Board |
Burt L. Nabors | - | 2024 | Member of Scientific & Medical Advisory Board |
David LaPre | 72 | 2024 | Independent Director |
Allan J. Camaisa | 63 | 2018 | CEO & Chairman of the Board |
E. Antonio Chiocca | - | 2024 | Member of the Scientific & Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review